Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 176   

Articles published

GSK 1,466.90 -14.60 (-0.99%)
price chart
GlaxoSmithKline plc Falls On Drop In Profits And Turnover
The share price of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is currently down over 3% following publication of a results announcement for the second quarter and interim management report for the half-year.
Should You Buy GlaxoSmithKline plc Or AstraZeneca plc?
GlaxoSmithKline It's been a disappointing year thus far for investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), with shares in the pharmaceutical company being down 6%. This does not compare favourably to the wider market (the FTSE 100 is up 1%), ...
Eyes Down For GlaxoSmithKline plc Results
gsk GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been overshadowed a bit of late by takeover attempts at rival AstraZeneca, and its share price has lagged a little - it's been see-sawing all year and is down around 8% over the past 12 months, ...
Related articles »  
Is GlaxoSmithKline plc A Safe Dividend Investment?
GlaxoSmithKline Half-time news that, on a constant-currency basis, turnover is down 7%, operating profit down 10% and earnings per share down 14% so far this year won't cheer shareholders of pharmaceutical giant GlaxoSmithKline (LSE: GSK) (NYSE: ...
GlaxoSmithKline plc trims 2014 forecast  ValueWalk
Why GlaxoSmithKline (GSK) Stock Is Falling Today  TheStreet.com
Related articles »  
Is GlaxoSmithKline plc The World's Most Undervalued Company?
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is cheap. Really cheap, there is no other way of putting it. Indeed, Glaxo currently trades at a valuation lower than all of its international peers within the biotechnology sector.
China to hold public trial of foreign couple who worked for GSK  TODAYonline
Related articles »  
Why GlaxoSmithKline (GSK) Stock Continues To Sink Today
"We rate GLAXOSMITHKLINE PLC (GSK) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Related articles »  
The Rising Pound Will Hit GlaxoSmithKline plc, BHP Billiton plc, ARM Holdings ...
A strong currency is a sign of global punching power, but it can leave investors on the ropes. Sterling's resurgence has dealt a few body blows to the FTSE 100, whose constituents generate more than three-quarters of their earnings overseas.
Related articles »  
GlaxoSmithKline plc Rating Reiterated by Barclays (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �equal weight� rating reaffirmed by stock analysts at Barclays in a report issued on Thursday.
GlaxoSmithKline plc (GSK) Plans Dividend of GBX 19  Intercooler
GlaxoSmithKline plc Stock Rating Reaffirmed by Credit Suisse (GSK)  WKRB News
Related articles »  
GSK Tumbles On Earnings Miss, Lowered EPS Guidance
GlaxoSmithKline plc (ADR) (GSK) reported results for the second quarter of its 2014 fiscal year (2QFY14) today, causing the stock to decline in pre-market trading.
After Another Shire PLC Bid, Could AstraZeneca plc Or GlaxoSmithKline plc Be ...
shire With Abbvie's �53.20 per share offer receiving a 'thumbs up' from the board of Shire (LSE: SHP), it means that shares in the healthcare stock have risen by 75% during the course of 2014.
Related articles »